Trademark Overview
On Friday, June 6, 2025, a trademark application was filed for CAJAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CAJAL THERAPEUTICS trademark a serial number of 99222350. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by Cajal Therapeutics Inc.. The CAJAL THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hematological, hepatological, ophthalmic, cardiometabolic, pulmonary, nephrological, respiratory, neurological, neuromuscular, gastrointestinal, hormonal, dermatological, psychiatric, and sexually transmitted diseases, conditions, and disorders.
Pharmaceutical research and development; drug discovery services; medical and scientific research.